Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses

Vaccine

Volumn 18, Issue 13, 2000, Pages 1151-1160

  Kato, Hidenori ^a   Bukawa, Hiroki ^a   Hagiwara, Eri ^a   Xin, Ke Qin ^a   Hamajima, Kenji ^a   Kawamoto, Susumu ^a   Sugiyama, Mitsugu ^a   Sugiyama, Mitsuru ^b   Noda, Etsunosuke ^b   Nishizaki, Masanosuke ^b   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Research Department   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN A ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 4; PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HOMOSEXUALITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, RECTAL; AIDS VACCINES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; BIOPOLYMERS; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDES; RECTUM; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC; VAGINA;

EID: 19244367476     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00385-0     Document Type: Article

References (39)

1. Forrest B.D. Women, HIV and mucosal immunity. Lancet. 337:1991;835-836.
2. Ho D.D., Schooley R.T., Rota T.R., et al. HTLV-III in the semen and blood of a healthy homosexual man. Science. 226:1984;451-453.
3. Borzy M.S., Connell R.S., Kiessling A.A. Detection of human immunodeficiency virus in cell-free seminal fluid. J. Acquired Immune. Defic. Syndr. 1:1988;419-424.
4. Nelson J.A., Wiley C.A., Reynolds Kohler C., et al. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet. 1:1988;259-262.
5. Bourinbaiar A.S., Phillips D.M. Transmission of human immunodeficiency virus from monocytes to epithelia. J. Acquired Immune. Defic. Syndr. 4:1991;56-63.
6. Amerongen H.M., Weltzin R., Farnet C.M., et al. Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J. Acquired Immune. Defic. Syndr. 4:1991;760-765.
7. Mazanec M.B., Kaetzel C.S., Lamm M.E., et al. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc. Natl. Acad. Sci. USA. 89:1992;6901-6905.
8. Bukawa H., Sekigawa K., Hamajima K., et al. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1:1995;681-685.
9. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature. 292:1981;413-417.
10. Hamajima K., Bukawa H., Fukushima J., et al. A macromolecular multicomponent peptide vaccine prepared using the glutaraldehyde conjugation method with strong immunogenicity for HIV-1. Clin. Immunol. Immunopathol. 77:1995;374-379.
11. Tam J.P. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA. 85:1988;5409-5413.
12. Divis M.L., Bernhard H., Shiota F.M., et al. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-base vaccine. Blood. 88:1996;202-210.
13. Okada E., Sasaki S., Iishi N., et al. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
14. Attman A.S., Johnson G.D., Prystowky M.B. Single proline substitutions in predicted a-helices of murine granulocyte-macrophage colony-stimulating factor resulted in a loss in bioactivity and altered glycosylation. J. Biol. Chem. 266:1991;5333-5341.
15. Tsuji T., Hamajima K., Fukushima J., et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinnoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J. Immunol. 158:1997;4008-4013.
16. Salk J., Bretscher P., Salk P.L., et al. A strategy for prophylactic vaccination against HIV. Science. 260:1993;1270-1272.
17. Bukawa H., Fukushima J., Hamajima K., et al. Antibody responses raised against a conformational V3 loop peptide of HIV-1. Microbiol. Immunol. 39:1995;607-614.
18. Achour A., Picard O., Zagury D., et al. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc. Natl. Acad. Sci. USA. 87:1990;7045-7049.
19. McKeating J.A., Cordell J., Dean C.J., et al. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology. 191:1992;732-742.
20. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
21. de Vos T., Dick T.A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J. Immunol. Meth. 141:1991;285-288.
22. Jackson R.J., Fujihashi K., Xu A.J., et al. Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant. Infect. Immun. 61:1993;4272-4279.
23. Fisher M.M., Nagy B., Bazin H., et al. Biliary transport of IgA: role of secretory component. Proc. Natl. Acad. Sci. USA. 76:1979;2008-2012.
24. Vaerman J.P., Heremans J.F., Bazin H., et al. Identification and some properties of rat secretory component. J. Immunol. 114:1975;265-269.
25. Parr M.B., Ren H.P., Russell L.D., et al. Urethral glands of the male mouse contain secretory component and immunoglobulin A plasma cells and are targets of testosterone. Biol. Reprod. 47:1992;1031-1039.
26. Nara P.L., Hatch W.C., Dunlop N.M., et al. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses. 3:1987;283-302.
27. Lai P.K., Donovan J., Takayama H., et al. Modification of human immunodeficiency viral replication by pine cone extracts. AIDS Res. Hum. Retroviruses. 6:1990;605-617.
28. Okuda K., Minami M., Ju S.T., et al. Functional association of idiotypic and I-J determinants on the antigen receptor of suppressor T cells. Proc. Natl. Acad. Sci. USA. 78:1981;4557-4561.
29. Favre N., Bordmann G., Rudin W. Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. J. Immunol. Methods. 204:1997;57-66.
30. Shirai A., Holmes K., Klinman D. Detection and quantitation of cells secreting IL-6 under physiologic conditions in BALB/c mice. J. Immunol. 150:1993;793-799.
31. Xu A.J., Aicher W.K., Taguchi T., et al. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 4:1992;433-445.
32. Clerici M., Lucey D.R., Zajec R.A., et al. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J. Immunol. 146:1991;2214-2219.
33. Staats H.F., Nichols W.G., Palker T.J. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:1996;462-472.
34. Bowen J.C., Nair S.K., Reddy R., et al. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with nonreplicating antigens. Immunology. 81:1994;338-342.
35. Bourguin I., Chardes T., Bout D. Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice. Infect. Immun. 61:1993;2082-2088.
36. Tsuji T., Fukushima J., Hamajima K., et al. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology. 90:1997;1-6.
37. Tsuji T., Hamajima K., Iishi N., et al. Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. 27:1997;782-787.
38. Sasaki S., Inamura K., Okuda K. Gene that induce immunity-DNA vaccines. Microbiol. Immunol. 43:1999;191-200.
39. Okuda K., Bukawa H., Hamajima K., et al. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products. AIDS Res Hum Retroviruses. 11:1995;933-943.